Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.167NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.267ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.267NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
B.1.267NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F1059.37US
B.1.165ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.165NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-11666.3China
B.1.165NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.554ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.554NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.554NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.243.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.243.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.243.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
A.2.5.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
A.2.5.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-19013.6China
A.2.5.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.450ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.450NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.450NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
AY.130ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.130NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
AY.130NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.444ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.444NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
B.1.444NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F92.4864US
AW.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AW.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
AW.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.268ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.268NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.268NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.344ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.344NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.344NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.103ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.103NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.103NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.485ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.485NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.485NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.119ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.119NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.119NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.276ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.276NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.276NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.1.111ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.111NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.1.111NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
B.1.36.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used